Tobin, W O <br/><br/>
Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke.  [electronic resource] 

 -  Journal of neurology  Jul 2014 
 - 1405-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-1459 
<br/><br/><label>Standard No.: </label>10.1007/s00415-014-7362-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aspirin--therapeutic use<br/>Clopidogrel<br/>Dipyridamole--therapeutic use<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Humans<br/>Ischemic Attack, Transient--blood<br/>Longitudinal Studies<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Protein Precursors--blood<br/>Statistics, Nonparametric<br/>Stroke--drug therapy<br/>Ticlopidine--analogs & derivatives<br/>Time Factors<br/>von Willebrand Factor--metabolism